share_log

中关村(000931.SZ):公司药品入选2024年国家医保目录

Beijing Centergate Technologies (000931.SZ): The company's Pharmaceutical has been included in the 2024 National Medical Insurance Directory.

Gelonghui Finance ·  Dec 11 18:09

Glory Holdings announced on December 11 that its wholly-owned subsidiary SIHUAN PHARM's Beijing Huasu, ShanDong Huasu, and SIHUAN PHARM's Duoduo Pharmaceutical have a total of 34 products selected in the "Medical Insurance Catalogue 2024". This includes products such as Bisoprolol Fumarate Tablets, Benidipine Hydrochloride Tablets, Oxycodone Hydrochloride Tablets, and Naloxone Hydrochloride Injection, which were originally included in the national medical insurance catalogue for 2023. There are no changes in the selected products compared to the "Medical Insurance Catalogue 2023". The future sales of the selected catalogue products may be impacted by various factors such as market environment changes, but will not have a significant impact on the company's current operating performance. The "Medical Insurance Catalogue 2024" will be officially implemented starting January 1, 2025.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment